Gizeh Perez-Tenorio

Publications

2024

Annelie Johansson, Huma Dar, Anna Nordenskjoeld, Gizeh Perez-Tenorio, Nicholas P. Tobin, Christina Yau, Christopher C. Benz, Laura J. Esserman, Laura J. van 't Veer, Bo Nordenskjöld, Olle Stål, Tommy Fornander, Linda S. Lindstroem (2024) Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial Journal of the National Cancer Institute (Article in journal) Continue to DOI

Josefine Sandström, Jens Bomanson, Gizeh Perez-Tenorio, Carolin Jönsson, Bo Nordenskjöld, Tommy Fornander, Linda S. Lindstrom, Olle Stål (2024) GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer npj Breast Cancer, Vol. 10, Article 78 (Article in journal) Continue to DOI

2022

Annelie Johansson, Huma Dar, Laura J. van t Veer, Nicholas P. Tobin, Gizeh Perez-Tenorio, Anna Nordenskjöld, Ulla Johansson, Johan Hartman, Lambert Skoog, Christina Yau, Christopher C. Benz, Laura J. Esserman, Olle Stål, Bo Nordenskjöld, Tommy Fornander, Linda S. Lindstrom (2022) Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial Journal of Clinical Oncology, Vol. 40, p. 4071-4082 (Article in journal) Continue to DOI

Jenny Pousette, Annelie Johansson, Carolin Jönsson, Tommy Fornander, Linda S. Lindström, Hans Olsson, Gizeh Perez-Tenorio (2022) Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (sTILs) in ER-Positive/HER2-Negative Postmenopausal Breast Cancer Patients Cancers, Vol. 14, Article 4844 (Article in journal) Continue to DOI

Annelie Johansson, Nancy Y. Yu, Adina Iftimi, Nicholas P. Tobin, Laura Van 'T Veer, Bo Nordenskjöld, Christopher C. Benz, Tommy Fornander, Gizeh Pérez-Tenorio, Olle Stål, Laura J. Esserman, Christina Yau, Linda S. Lindström (2022) Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature International Journal of Cancer, Vol. 150, p. 2072-2082 (Article in journal) Continue to DOI